This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Conagra (CAG) Unveils Product Innovations to Drive Growth
by Zacks Equity Research
Conagra (CAG) unveils an impressive line-up of product innovations including meals and sides inspired from great flavor and quality, including plant-based offerings.
Pilgrim's Pride (PPC) Benefits on Capacity & Portfolio Growth
by Zacks Equity Research
Pilgrim's Pride (PPC) prudent operational strategies, including buyouts and capacity expansion for key products, are driving performance across key markets.
Conagra's (CAG) Faster Cage-Free Egg Transition to Cheer Consumers
by Zacks Equity Research
Conagra (CAG) now targets using 100% cage-free eggs by fiscal 2024-end compared with the earlier plan of fiscal 2025. This goes in line with consumers' focus on animal welfare.
McCormick (MKC) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
McCormick's (MKC) second-quarter fiscal 2021 performance is likely to reflect gains from pandemic-led demand and prudent acquisitions. However, increased pandemic-induced costs are a worry.
Hain Celestial (HAIN) on Track With Transformation Strategy
by Zacks Equity Research
Hain Celestial's (HAIN) transformation strategy includes simplifying portfolio and identifying areas of productivity savings. Tough year-on-year comparison due to lapping of pandemic-led benefits is a downside.
Hershey (HSY) Buys Lily's, Boosts Better-For-You Brand Portfolio
by Zacks Equity Research
Hershey (HSY) acquires Lily's, a leading better-for-you confectionery brand, for $425 million. The buyout is in sync with Hershey's focus on multi-pronged better-for-you snacking strategy.
Deploy DuPont Technique to Land on 5 Top-Ranked Stocks
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Looking for a Growth Stock? 3 Reasons Why Medifast (MED) is a Solid Choice
by Zacks Equity Research
Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
United Natural (UNFI) Gains on E-Commerce Sales, Prudent Buyouts
by Zacks Equity Research
United Natural (UNFI) is benefiting from strength in online sales, thanks to increased e-commerce solutions offered by the company. Also, its strategic buyouts are yielding.
Zacks.com featured highlights include: Medifast, Boyd Gaming, National Vision Holdings, Gentherm and Generac
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, Boyd Gaming, National Vision Holdings, Gentherm and Generac
Philip Morris (PM) Focuses on Transformation, Shifts Headquarters
by Zacks Equity Research
Philip Morris (PM) unveils shifting of its corporate headquarters to Connecticut, which is likely to speed up its transformation toward a smoke-free future.
Kellogg (K) Expands Sodexo Partnership to Grow Plant-Based Options
by Zacks Equity Research
Kellogg (K) is expanding its partnership with Sodexo to introduce Incogmeato Burger Patties by MorningStar Farms at over 3,000 locations.
5 Top-Ranked Liquid Stocks to Enrich Your Portfolio in 2021
by Aniruddha Ganguly
Here are five top-ranked liquid stocks -- Medifast (MED), Boyd Gaming (BYD), National Vision Holdings (EYE), Gentherm (THRM) and Generac Holdings (GNRC) -- which investors can tap for alluring returns.
Albertsons (ACI), DoorDash Tie Up to Expedite Grocery Delivery
by Zacks Equity Research
Albertsons (ACI) partners with DoorDash to boost on-demand grocery delivery services, thereby enriching the shopping experience of its customers.
The J.M. Smucker (SJM) Up About 15% YTD: Will Momentum Stay?
by Zacks Equity Research
The J.M. Smucker Company (SJM) is poised to benefit from solid pricing and a revival in the Away From Home division, though high costs are concerning.
Nu Skin (NUS) Looks Promising: Stock Up More Than 45% in a Year
by Zacks Equity Research
Nu Skin (NUS) is focused on empowering sales leaders and customers through product launches and engaging technology platforms, among other initiatives.
Kraft Heinz (KHC) Up More Than 17% in 6 Months: More Room to Run?
by Zacks Equity Research
Kraft Heinz's (KHC) operating model, which incorporates five key elements, including People with Purpose, Consumer Platforms, Ops Center, Partner Program and Fuel Our Growth, bodes well.
Medifast (MED) Stock More Than Doubles in a Year: Here's Why
by Zacks Equity Research
Medifast (MED) has been benefiting from consumers' increased inclination toward health, along with a solid OPTAVIA coach-based model. These have been helping the company draw new clients.
Mondelez (MDLZ) Poised on Prudent Acquisitions & Innovation
by Zacks Equity Research
Mondelez (MDLZ) is keen on expanding its business through prudent acquisitions. Also, the company's effective cost-saving initiatives are working well.
SpartanNash (SPTN) Adds Value to Online Grocery Shopping
by Zacks Equity Research
SpartanNash's (SPTN) announces greater benefits exclusively for its Fast Lane subscribers to make grocery online shopping easily available at reasonable prices.
Pilgrim's Pride (PPC) to Buy Kerry's Meats and Meals Business
by Zacks Equity Research
Pilgrim's Pride (PPC) to buy the Kerry Consumer Foods' Meats and Meals business, which will add key value-added protein and renowned brands to its portfolio.
4 Stocks With High Net Income Ratio to Scoop Up
by Nitish Marwah
High net income ratio stocks for the day include Teledyne Technologies (TDY), Medifast, Inc. (MED), PetroChina Company (PTR), and Tilly's, Inc. (TLYS).
Forget Campbell Soup (CPB), Buy These Food Stocks Instead
by Ansuiya Mohta
While inflation and higher supply-chain costs mar Campbell Soup (CPB), stocks like Medifast (MED), Darling Ingredients (DAR) and Nomad Foods (NOMD) are poised to gain on customer-friendly innovation.
Medifast (MED) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Medifast (MED) has been struggling lately, but the selling pressure may be coming to an end soon
Campbell Soup (CPB) Looks Troubled: Cost Inflation a Major Hurdle
by Zacks Equity Research
Campbell Soup (CPB) is battling margin concerns due to elevated inflation, a rise in supply-chain expenses and some executional headwinds related to the transformation plan. Management recently cut the EPS view.